FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3694211000001104: Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25951301000001112 Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25951401000001116 Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Is a Cyclophosphamide 50mg tablets 100 tablet true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Is pack of Endoxana 50mg tablets (Baxter Healthcare Ltd) false Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has active ingredient Cyclophosphamide false Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has active ingredient Cyclophosphamide monohydrate false Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has AMP Endoxana 50mg tablets (Baxter Healthcare Ltd) true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cyclophosphamide true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has specific active ingredient Cyclophosphamide monohydrate false Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has specific active ingredient Cyclophosphamide monohydrate true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has basis of strength substance Cyclophosphamide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start